Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Nov 15;25(22):4455–4463. doi: 10.1093/nar/25.22.4455

The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60.

P A Defossez 1, J L Baert 1, M Monnot 1, Y de Launoit 1
PMCID: PMC147095  PMID: 9358152

Abstract

Transcription factors are modular entities built up of discrete domains, some devoted to DNA binding and others permitting transcriptional modulation. The structure of DNA binding domains has been thoroughly investigated and structural classes clearly defined. In sharp contrast, the structural constraints put on transactivating regions, if any, are mostly unknown. Our investigations focus on ERM, a eukaryotic transcription factor of the ETS family. We have previously shown that ERM harbours two transactivating domains (TADs) with distinct functional features: AD1 lies in the first 72 amino acids of ERM, while AD2 sits in the last 62. Here we show that AD1 is a bona fide acidic TAD, for it activated transcription in yeast cells, while AD2 did not. AD1 contains a 20 amino acid stretch predicted to form an alpha-helix that is found unchanged in the related PEA3 and ER81 transcription factors. Circular dichroism analysis revealed that a 32 amino acid peptide encompassing this region is unstructured in water but folds into a helix when the hydrophobic solvent trifluoroethanol is added. The isolated helix was sufficient to activate transcription and mutations predicted to disrupt it dramatically affected AD1-driven transactivation, whereas mutations decreasing its acidity had more gentle effects. A phenylalanine residue within the helix was particularly sensitive to mutations. Finally, we observed that ERM bound TAFII60 via AD1 and bound TBP and TAFII40, presumably via other activation domains.

Full Text

The Full Text of this article is available as a PDF (171.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelmant G., Bègue A., Stéhelin D., Laudet V. A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3553–3558. doi: 10.1073/pnas.93.8.3553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albagli O., Soudant N., Ferreira E., Dhordain P., Dewitte F., Begue A., Flourens A., Stehelin D., Leprince D. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies. Oncogene. 1994 Nov;9(11):3259–3271. [PubMed] [Google Scholar]
  3. Argenton F., Arava Y., Aronheim A., Walker M. D. An activation domain of the helix-loop-helix transcription factor E2A shows cell type preference in vivo in microinjected zebra fish embryos. Mol Cell Biol. 1996 Apr;16(4):1714–1721. doi: 10.1128/mcb.16.4.1714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ben-David Y., Giddens E. B., Letwin K., Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991 Jun;5(6):908–918. doi: 10.1101/gad.5.6.908. [DOI] [PubMed] [Google Scholar]
  5. Blair W. S., Bogerd H. P., Madore S. J., Cullen B. R. Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module. Mol Cell Biol. 1994 Nov;14(11):7226–7234. doi: 10.1128/mcb.14.11.7226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bories J. C., Willerford D. M., Grévin D., Davidson L., Camus A., Martin P., Stéhelin D., Alt F. W. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 1995 Oct 19;377(6550):635–638. doi: 10.1038/377635a0. [DOI] [PubMed] [Google Scholar]
  7. Brown T. A., McKnight S. L. Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins. Genes Dev. 1992 Dec;6(12B):2502–2512. doi: 10.1101/gad.6.12b.2502. [DOI] [PubMed] [Google Scholar]
  8. Brunner D., Dücker K., Oellers N., Hafen E., Scholz H., Klämbt C. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature. 1994 Aug 4;370(6488):386–389. doi: 10.1038/370386a0. [DOI] [PubMed] [Google Scholar]
  9. Chang C., Gralla J. D. Properties of initiator-associated transcription mediated by GAL4-VP16. Mol Cell Biol. 1993 Dec;13(12):7469–7475. doi: 10.1128/mcb.13.12.7469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chou P. Y., Fasman G. D. Empirical predictions of protein conformation. Annu Rev Biochem. 1978;47:251–276. doi: 10.1146/annurev.bi.47.070178.001343. [DOI] [PubMed] [Google Scholar]
  11. Chumakov A. M., Chen D. L., Chumakova E. A., Koeffler H. P. Localization of the c-ets-2 transactivation domain. J Virol. 1993 Apr;67(4):2421–2425. doi: 10.1128/jvi.67.4.2421-2425.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cress W. D., Triezenberg S. J. Critical structural elements of the VP16 transcriptional activation domain. Science. 1991 Jan 4;251(4989):87–90. doi: 10.1126/science.1846049. [DOI] [PubMed] [Google Scholar]
  13. Das G., Hinkley C. S., Herr W. Basal promoter elements as a selective determinant of transcriptional activator function. Nature. 1995 Apr 13;374(6523):657–660. doi: 10.1038/374657a0. [DOI] [PubMed] [Google Scholar]
  14. Degnan B. M., Degnan S. M., Naganuma T., Morse D. E. The ets multigene family is conserved throughout the Metazoa. Nucleic Acids Res. 1993 Jul 25;21(15):3479–3484. doi: 10.1093/nar/21.15.3479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Emami K. H., Navarre W. W., Smale S. T. Core promoter specificities of the Sp1 and VP16 transcriptional activation domains. Mol Cell Biol. 1995 Nov;15(11):5906–5916. doi: 10.1128/mcb.15.11.5906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  17. Giniger E., Ptashne M. Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit. Nature. 1987 Dec 17;330(6149):670–672. doi: 10.1038/330670a0. [DOI] [PubMed] [Google Scholar]
  18. Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994 Apr 22;77(2):307–316. doi: 10.1016/0092-8674(94)90322-0. [DOI] [PubMed] [Google Scholar]
  19. Guarente L. Transcriptional coactivators in yeast and beyond. Trends Biochem Sci. 1995 Dec;20(12):517–521. doi: 10.1016/s0968-0004(00)89120-3. [DOI] [PubMed] [Google Scholar]
  20. Hagemeier C., Bannister A. J., Cook A., Kouzarides T. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1580–1584. doi: 10.1073/pnas.90.4.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hahn S. Transcription. Efficiency in activation. Nature. 1993 Jun 24;363(6431):672–673. doi: 10.1038/363672a0. [DOI] [PubMed] [Google Scholar]
  22. Herschlag D., Johnson F. B. Synergism in transcriptional activation: a kinetic view. Genes Dev. 1993 Feb;7(2):173–179. doi: 10.1101/gad.7.2.173. [DOI] [PubMed] [Google Scholar]
  23. Higashino F., Yoshida K., Noumi T., Seiki M., Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene. 1995 Apr 6;10(7):1461–1463. [PubMed] [Google Scholar]
  24. Hill C. S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell. 1995 Jun 30;81(7):1159–1170. doi: 10.1016/s0092-8674(05)80020-0. [DOI] [PubMed] [Google Scholar]
  25. Janknecht R. Analysis of the ERK-stimulated ETS transcription factor ER81. Mol Cell Biol. 1996 Apr;16(4):1550–1556. doi: 10.1128/mcb.16.4.1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jeon I. S., Davis J. N., Braun B. S., Sublett J. E., Roussel M. F., Denny C. T., Shapiro D. N. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995 Mar 16;10(6):1229–1234. [PubMed] [Google Scholar]
  27. Karim F. D., Urness L. D., Thummel C. S., Klemsz M. J., McKercher S. R., Celada A., Van Beveren C., Maki R. A., Gunther C. V., Nye J. A. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 1990 Sep;4(9):1451–1453. doi: 10.1101/gad.4.9.1451. [DOI] [PubMed] [Google Scholar]
  28. Kaya M., Yoshida K., Higashino F., Mitaka T., Ishii S., Fujinaga K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene. 1996 Jan 18;12(2):221–227. [PubMed] [Google Scholar]
  29. Klaes A., Menne T., Stollewerk A., Scholz H., Klämbt C. The Ets transcription factors encoded by the Drosophila gene pointed direct glial cell differentiation in the embryonic CNS. Cell. 1994 Jul 15;78(1):149–160. doi: 10.1016/0092-8674(94)90581-9. [DOI] [PubMed] [Google Scholar]
  30. Klemsz M. J., Maki R. A. Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol. 1996 Jan;16(1):390–397. doi: 10.1128/mcb.16.1.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kussie P. H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A. J., Pavletich N. P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996 Nov 8;274(5289):948–953. doi: 10.1126/science.274.5289.948. [DOI] [PubMed] [Google Scholar]
  32. Laget M. P., Defossez P. A., Albagli O., Baert J. L., Dewitte F., Stehelin D., de Launoit Y. Two functionally distinct domains responsible for transactivation by the Ets family member ERM. Oncogene. 1996 Mar 21;12(6):1325–1336. [PubMed] [Google Scholar]
  33. Laudet V., Niel C., Duterque-Coquillaud M., Leprince D., Stehelin D. Evolution of the ets gene family. Biochem Biophys Res Commun. 1993 Jan 15;190(1):8–14. doi: 10.1006/bbrc.1993.1002. [DOI] [PubMed] [Google Scholar]
  34. Leprince D., Gegonne A., Coll J., de Taisne C., Schneeberger A., Lagrou C., Stehelin D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature. 1983 Nov 24;306(5941):395–397. doi: 10.1038/306395a0. [DOI] [PubMed] [Google Scholar]
  35. Leuther K. K., Salmeron J. M., Johnston S. A. Genetic evidence that an activation domain of GAL4 does not require acidity and may form a beta sheet. Cell. 1993 Feb 26;72(4):575–585. doi: 10.1016/0092-8674(93)90076-3. [DOI] [PubMed] [Google Scholar]
  36. Macleod K., Leprince D., Stehelin D. The ets gene family. Trends Biochem Sci. 1992 Jul;17(7):251–256. doi: 10.1016/0968-0004(92)90404-w. [DOI] [PubMed] [Google Scholar]
  37. Minor D. L., Jr, Kim P. S. Context-dependent secondary structure formation of a designed protein sequence. Nature. 1996 Apr 25;380(6576):730–734. doi: 10.1038/380730a0. [DOI] [PubMed] [Google Scholar]
  38. Monté D., Baert J. L., Defossez P. A., de Launoit Y., Stéhelin D. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene. 1994 May;9(5):1397–1406. [PubMed] [Google Scholar]
  39. Monté D., Coutte L., Dewitte F., Defossez P. A., Le Coniat M., Stéhelin D., Berger R., de Launoit Y. Genomic organization of the human ERM (ETV5) gene, a PEA3 group member of ETS transcription factors. Genomics. 1996 Jul 1;35(1):236–240. doi: 10.1006/geno.1996.0345. [DOI] [PubMed] [Google Scholar]
  40. Moreau-Gachelin F., Tavitian A., Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988 Jan 21;331(6153):277–280. doi: 10.1038/331277a0. [DOI] [PubMed] [Google Scholar]
  41. Nakae K., Nakajima K., Inazawa J., Kitaoka T., Hirano T. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J Biol Chem. 1995 Oct 6;270(40):23795–23800. doi: 10.1074/jbc.270.40.23795. [DOI] [PubMed] [Google Scholar]
  42. Nunn M. F., Seeburg P. H., Moscovici C., Duesberg P. H. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature. 1983 Nov 24;306(5941):391–395. doi: 10.1038/306391a0. [DOI] [PubMed] [Google Scholar]
  43. O'Hare P., Williams G. Structural studies of the acidic transactivation domain of the Vmw65 protein of herpes simplex virus using 1H NMR. Biochemistry. 1992 Apr 28;31(16):4150–4156. doi: 10.1021/bi00131a035. [DOI] [PubMed] [Google Scholar]
  44. O'Neill E. M., Rebay I., Tjian R., Rubin G. M. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell. 1994 Jul 15;78(1):137–147. doi: 10.1016/0092-8674(94)90580-0. [DOI] [PubMed] [Google Scholar]
  45. Rebay I., Rubin G. M. Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell. 1995 Jun 16;81(6):857–866. doi: 10.1016/0092-8674(95)90006-3. [DOI] [PubMed] [Google Scholar]
  46. Reese J. C., Apone L., Walker S. S., Griffin L. A., Green M. R. Yeast TAFIIS in a multisubunit complex required for activated transcription. Nature. 1994 Oct 6;371(6497):523–527. doi: 10.1038/371523a0. [DOI] [PubMed] [Google Scholar]
  47. Roberts S. G., Green M. R. Activator-induced conformational change in general transcription factor TFIIB. Nature. 1994 Oct 20;371(6499):717–720. doi: 10.1038/371717a0. [DOI] [PubMed] [Google Scholar]
  48. Rost B. PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 1996;266:525–539. doi: 10.1016/s0076-6879(96)66033-9. [DOI] [PubMed] [Google Scholar]
  49. Rost B., Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol. 1993 Jul 20;232(2):584–599. doi: 10.1006/jmbi.1993.1413. [DOI] [PubMed] [Google Scholar]
  50. Sadowski I., Ptashne M. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 1989 Sep 25;17(18):7539–7539. doi: 10.1093/nar/17.18.7539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sauer F., Hansen S. K., Tjian R. DNA template and activator-coactivator requirements for transcriptional synergism by Drosophila bicoid. Science. 1995 Dec 15;270(5243):1825–1828. doi: 10.1126/science.270.5243.1825. [DOI] [PubMed] [Google Scholar]
  52. Schmitz M. L., dos Santos Silva M. A., Altmann H., Czisch M., Holak T. A., Baeuerle P. A. Structural and functional analysis of the NF-kappa B p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J Biol Chem. 1994 Oct 14;269(41):25613–25620. [PubMed] [Google Scholar]
  53. Schneikert J., Lutz Y., Wasylyk B. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family. Oncogene. 1992 Feb;7(2):249–256. [PubMed] [Google Scholar]
  54. Scott E. W., Simon M. C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994 Sep 9;265(5178):1573–1577. doi: 10.1126/science.8079170. [DOI] [PubMed] [Google Scholar]
  55. Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M., Hida K., Kohgo T., Amemiya A., Yoshida K. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am J Pathol. 1996 Mar;148(3):693–700. [PMC free article] [PubMed] [Google Scholar]
  56. Siddique H. R., Rao V. N., Lee L., Reddy E. S. Characterization of the DNA binding and transcriptional activation domains of the erg protein. Oncogene. 1993 Jul;8(7):1751–1755. [PubMed] [Google Scholar]
  57. Silverman N., Agapite J., Guarente L. Yeast ADA2 protein binds to the VP16 protein activation domain and activates transcription. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11665–11668. doi: 10.1073/pnas.91.24.11665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sumarsono S. H., Wilson T. J., Tymms M. J., Venter D. J., Corrick C. M., Kola R., Lahoud M. H., Papas T. S., Seth A., Kola I. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature. 1996 Feb 8;379(6565):534–537. doi: 10.1038/379534a0. [DOI] [PubMed] [Google Scholar]
  59. Thut C. J., Chen J. L., Klemm R., Tjian R. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science. 1995 Jan 6;267(5194):100–104. doi: 10.1126/science.7809597. [DOI] [PubMed] [Google Scholar]
  60. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev. 1994 Feb;4(1):96–101. doi: 10.1016/0959-437x(94)90097-3. [DOI] [PubMed] [Google Scholar]
  61. Trimble M. S., Xin J. H., Guy C. T., Muller W. J., Hassell J. A. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene. 1993 Nov;8(11):3037–3042. [PubMed] [Google Scholar]
  62. Van Hoy M., Leuther K. K., Kodadek T., Johnston S. A. The acidic activation domains of the GCN4 and GAL4 proteins are not alpha helical but form beta sheets. Cell. 1993 Feb 26;72(4):587–594. doi: 10.1016/0092-8674(93)90077-4. [DOI] [PubMed] [Google Scholar]
  63. Verrijzer C. P., Tjian R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem Sci. 1996 Sep;21(9):338–342. [PubMed] [Google Scholar]
  64. Voraberger G., Schäfer R., Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 1991 Oct 15;147(8):2777–2786. [PubMed] [Google Scholar]
  65. Walker S., Greaves R., O'Hare P. Transcriptional activation by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding. Mol Cell Biol. 1993 Sep;13(9):5233–5244. doi: 10.1128/mcb.13.9.5233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Wang C. Y., Petryniak B., Ho I. C., Thompson C. B., Leiden J. M. Evolutionarily conserved Ets family members display distinct DNA binding specificities. J Exp Med. 1992 May 1;175(5):1391–1399. doi: 10.1084/jem.175.5.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Wasylyk B., Hahn S. L., Giovane A. The Ets family of transcription factors. Eur J Biochem. 1993 Jan 15;211(1-2):7–18. doi: 10.1007/978-3-642-78757-7_2. [DOI] [PubMed] [Google Scholar]
  68. Whitmarsh A. J., Shore P., Sharrocks A. D., Davis R. J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 1995 Jul 21;269(5222):403–407. doi: 10.1126/science.7618106. [DOI] [PubMed] [Google Scholar]
  69. Xin J. H., Cowie A., Lachance P., Hassell J. A. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 1992 Mar;6(3):481–496. doi: 10.1101/gad.6.3.481. [DOI] [PubMed] [Google Scholar]
  70. Yang B. S., Hauser C. A., Henkel G., Colman M. S., Van Beveren C., Stacey K. J., Hume D. A., Maki R. A., Ostrowski M. C. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol. 1996 Feb;16(2):538–547. doi: 10.1128/mcb.16.2.538. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES